Hayden is an assistant editor for The American Journal of Managed Care® (AJMC®) and joined AJMC® in 2021, where she produces written and video content covering multiple disease states.
She has a BA in journalism & media studies from Rutgers University. You can connect with Hayden on LinkedIn.
People With HIV at Much Higher Risk of Depression, SuicideApril 19th 2023
In the first 2 years after receiving an HIV diagnosis, people with HIV were about 3 times more likely to develop depression, use antidepressants, and undergo electroconvulsive therapy—and 10 times more likely to commit suicide—compared with people without HIV.
Pitavastatin Calcium Linked to 35% Reduced CVD Risk In People With HIVApril 14th 2023
According to interim results from the REPRIEVE study, individuals with HIV who took the daily statin experienced a 35% reduced risk of major adverse cardiovascular (CVD) events, compared with those who received a placebo.
Researchers Develop Predictive Model for Kidney Function Decline in Adults With T2DApril 7th 2023
Researchers developed a reliable prediction model for kidney function decline in adults with type 2 diabetes and early to moderately progressed chronic kidney disease, which was externally validated and made publicly available via a web-based application.
PLWH Who Inject Drugs More Likely to Seek Treatment Following Group SessionsApril 7th 2023
Participants with HIV who inject drugs were more likely to initiate antiretroviral therapy and utilize substance use care after participating in group stigma-coping sessions, compared with those who received usual services.
Several ACA Preventive Services “Up for Grabs” Following Federal RulingMarch 31st 2023
The ruling does not completely get rid of all preventive services coverage under the Affordable Care Act; it only applies to updates or new recommendations made by the US Preventative Services Task Force since March 2010.
Dr Jeremy Wigginton: Health Care Happens All the Time; Employers Need to Engage Their PopulationMarch 27th 2023
For employers, keeping members engaged with their health care is one of the key factors that leads to better outcomes, said Jeremy Wigginton, MD, vice president of health quality and innovation at Blue Cross and Blue Shield of Louisiana.
Auditory Differences Between Children With and Without HIVMarch 27th 2023
Similar to findings among young adults, children with HIV in Tanzania were found to have lower distortion product otoacoustic emissions (DPOAEs) and auditory brainstem responses (ABR) wave V amplitudes, compared with children without HIV.
How Real-Time Benefit Check Can Improve Prescriber Decision-Making and Treatment UptakeMarch 25th 2023
Michael Burger, senior consultant at Point-of-Care Partners, explains that real-time benefit check lets physicians know how much a drug will cost the patient at the time they're writing the prescription, allowing them to give the patient a treatment they know they can afford.
What Are Some Health Plan Best Practices Surrounding Oncology Therapy Coverage?March 25th 2023
In this AMCP Market Insights session, panelists discussed best practices and challenges when it comes to prescribing antibody drug conjugates, from the payer, provider, and patient perspectives, based on survey findings.
Jeffrey Casberg on Breakthrough Ophthalmic Drugs That Payers, Pharmacists Should Pay Attention toMarch 25th 2023
Among these treatments is an aflibercept product with improved dosing for the patient that is coming up for approval in a few months, explained Jeffrey Casberg, senior director of pharmacy at IPD Analytics.
Dr Yuqian Liu Discusses Surrogate End Points, Formulary Management in the Accelerated Approval PathwayMarch 24th 2023
Advantages to using surrogate vs clinical end points in drug approvals include earlier access, but there can be concerns about the efficacy and end result of the drug, said Yuqian Liu, PharmD, senior director of specialty clinical solutions at Magellan Rx Management.
Dr Ben Urick Explains Challenges With Current Literature Linking Medication Adherence to Medical Cost OffsetsMarch 23rd 2023
Some challenges linking medication adherence to medical cost offsets include the potential of reverse causality, omitted variable bias, how adherence is measured between studies, and the outdated nature of some of the most-cited literature, said Ben Urick, PharmD, PhD, principal health outcomes researcher at Prime Therapeutics.
Dr Kevan Herold on Living With T1D: “There's Nothing You Do Without Thinking About It”March 17th 2023
It's harder for younger children to deal with the complexities of managing type 1 diabetes (T1D), so a delayed diagnosis even by a few years is a big deal, said Kevan Herold, MD, professor of immunobiology and medicine at Yale School of Medicine.
AMCP 2023 Will Cover Biosimilars, Inflation Reduction Act, and Much More, Says Kimberly WestrichMarch 16th 2023
Kimberly Westrich, director of value and access strategy at AmerisourceBergen, previews AMCP 2023 and her preconference session about incorporating value framework assessments into coverage and reimbursement decision-making.